Trexquant Investment LP Rocket Pharmaceuticals, Inc. Transaction History

Trexquant Investment LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$39.41 - $47.25 $223,888 - $268,427	-5,681 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$43.34 - $65.91 $547,904 - $833,234	-12,642 Reduced 69.0%	5,681 $252,000
Q4 2020 Feb 11, 2021	BUY	$23.3 - $59.57 $426,925 - $1.09 Million	18,323 New	18,323 $1.01 Million
Q1 2019 May 13, 2019	SELL	$13.45 - $19.01 $196,396 - $277,584	-14,602 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$11.21 - $23.53 $163,688 - $343,585	14,602 New	14,602 $216,000

209

93.2M

319K

70.3K

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $1.07B
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.